ephedrine sulfate
Generic: ephedrine sulfate
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
ephedrine sulfate
Generic Name
ephedrine sulfate
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION
Routes
Active Ingredients
ephedrine sulfate 50 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
65219-257
Product ID
65219-257_453036d8-bcc1-45a2-a905-edb03a8b743a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209646
Listing Expiration
2026-12-31
Marketing Start
2020-10-31
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65219257
Hyphenated Format
65219-257
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ephedrine sulfate (source: ndc)
Generic Name
ephedrine sulfate (source: ndc)
Application Number
ANDA209646 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 50 mg/mL
Packaging
- 25 VIAL, GLASS in 1 CARTON (65219-257-01) / 1 mL in 1 VIAL, GLASS (65219-257-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "453036d8-bcc1-45a2-a905-edb03a8b743a", "openfda": {"upc": ["0365219257004"], "unii": ["U6X61U5ZEG"], "rxcui": ["1116294"], "spl_set_id": ["5ecd9746-25c7-4bd4-9503-eb97e7db5aa5"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, GLASS in 1 CARTON (65219-257-01) / 1 mL in 1 VIAL, GLASS (65219-257-00)", "package_ndc": "65219-257-01", "marketing_start_date": "20201031"}], "brand_name": "Ephedrine Sulfate", "product_id": "65219-257_453036d8-bcc1-45a2-a905-edb03a8b743a", "dosage_form": "INJECTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Releasing Agent [EPC]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "65219-257", "generic_name": "Ephedrine Sulfate", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ephedrine Sulfate", "active_ingredients": [{"name": "EPHEDRINE SULFATE", "strength": "50 mg/mL"}], "application_number": "ANDA209646", "marketing_category": "ANDA", "marketing_start_date": "20201031", "listing_expiration_date": "20261231"}